John is a director at EY-Parthenon, Quantitative Strategy and Solutions, Ernst & Young LLP. He is a consultant experienced in advising clients across sectors on leveraging emerging technologies and advanced data-driven approaches to develop and execute impactful solutions to their most complex challenges.
John has over 25 years of experience spanning from advanced biotechnologies, biomanufacturing, medical devices, diagnostics, vaccines and therapeutics, to cutting-edge nanofabrication techniques in the semiconductor industry.
John previous served as a lead scientist at a technology consulting and analytics firm, where he led client engagements in moon-shot R&D programs in the biotechnology, medtech, advanced manufacturing and national intelligence practices.
John has served as a Postdoctoral Fellow in Biomaterials at the International Center for Materials Nanoarchitectonics within the National Institute for Materials Science in Tsukuba, Japan; holds a PhD in Bioengineering from the University of Washington in Seattle; and holds a BS in Environmental Engineering from the University of Southern California.
How John is building a better working world
“Complex problems require innovative strategies enabled by new technology, which are best informed through the incorporation of diverse perspectives. Through collaboration with colleagues around the globe, I work to combine advanced technical and analytical approaches into novel and effective solutions that meet today’s challenges, provide confidence in the future, and ultimately transform business and society.”